| Income Statement |
| Total Revenue | 364.71M |
|
| Revenues (USD) | 364.71M |
| Gross Profit | 364.71M |
| Operating Expenses | 350.07M |
| Research and Development Expense | 93.86M |
| Selling, General and Administrative Expense | 194.89M |
| Operating Income | 14.64M |
| Income Tax Expense | 614.00K |
| Net Income | 16.54M |
| Net Income Common Stock | 16.54M |
| Net Income Common Stock (USD) | 16.54M |
| Consolidated Income | 16.54M |
| Earnings per Basic Share | 0.17 |
| Earnings per Basic Share (USD) | 0.17 |
| Earnings per Diluted Share | 0.16 |
| Earning Before Interest & Taxes (EBIT) | 17.15M |
| Earning Before Interest & Taxes (USD) | 17.15M |
| Weighted Average Shares | 96.57M |
| Weighted Average Shares Diluted | 109.72M |
| Balance Sheet |
| Cash and Equivalents | 982.28M |
| Cash and Equivalents (USD) | 982.28M |
| Investments | 1.88B |
| Property, Plant & Equipment Net | 68.20M |
| Total Assets | 3.17B |
| Total Debt | 2.06B |
| Total Liabilities | 2.37B |
| Accumulated Retained Earnings (Deficit) | -347.66M |
| Shareholders Equity | 797.49M |
| Shareholders Equity (USD) | 797.49M |
| Total Debt (USD) | 2.06B |
| Goodwill and Intangible Assets | 67.06M |
| Trade and Non-Trade Payables | 145.21M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.13M |
| Net Cash Flow from Financing | 93.49M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 50.94M |
| Capital Expenditure | -6.25M |
| Issuance (Purchase) of Equity Shares | 923.00K |
| Issuance (Repayment) of Debt Securities | 72.89M |
| Net Cash Flow from Investing | 94.08M |
| Net Cash Flow - Investment Acquisitions and Disposals | 101.05M |
| Net Cash Flow from Operations | -136.63M |
| Share Based Compensation | 44.47M |